Quality of Randomized Controlled Trials Reporting in the Primary Treatment of Brain Tumors
The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Purpose: To assess the reporting quality of randomized controlled trials (RCTs) in the primary treatment of brain tumors and to identify significant predictors of quality. Patients and Methods: Two investigators searched MEDLINE, EMBASE, and bibliographies of retrieved articles for RCTs in the primary treatment of brain tumors published between January 1990 and December 2004. We assessed the quality of overall reporting and key methodologic factors reporting (allocation concealment, blinding, and intention to treat [ITT]). Two investigators also rated articles independently using items from the revised Consolidated Standards of Reporting Trials statement. A generalized estimated equation was used to generate regression models that identified significant factors associated with quality of reporting. Results: We retrieved 74 relevant RCTs that randomly assigned 14,498 brain tumor patients. The quality of overall reporting has improved during the last 15 years, but eight of the 15 methodologic items were reported in less than 50% of trials. In the appraisal of the reporting quality of key methodologies, allocation concealment, blinding, and adherence to the ITT principle were reported in less than 30% of articles. Multivariable regression models revealed that an impact factor more than 1.66, publication after 1995, and sample size more than 280 were significant factors associated with better overall reporting, whereas complete industrial funding, impact factors more than 2.64, and positive primary outcomes were predictors of higher ratings of the three most important methodologic qualities. Conclusion: Despite improvement in general reporting quality, key methodologies that safeguard against biases may still benefit from better description. Significant factors associated with better reporting may act as surrogates for other characteristics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moher, D., Pham, B., Jones, A., Cook, D. J., Jadad, A. R., Moher, M., Tugwell, P., & Klassen, T. P. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01085-x · Cited by 3,560
What is meant by intention to treat analysis? Survey of published randomised controlled trials
Hollis, S., & Campbell, F. (1999) · BMJ · doi:10.1136/bmj.319.7211.670 · Cited by 2,160
Balk, E. M. (2002) · JAMA · doi:10.1001/jama.287.22.2973 · Cited by 478 · cited 1×
“Rating of Key Methodologic Qualities We used the reporting of allocation concealment, blinding, and analysis that adhered to the intention-to-treat principle (ITT) as key methodologic domains because omission of these three qualities has been associated with bias and distortions of treatment effect estimates by 20% to…”
MethodQuality of Reporting of Randomized Trials as a Measure of Methodologic Quality
Huwiler-Müntener, K. (2002) · JAMA · doi:10.1001/jama.287.21.2801 · Cited by 397 · cited 1×
“measures of RCT methodology for a separate assessment (see Rating of Key Methodologic Qualities) because a study found deficiencies in the reporting of key methodologic factors even among articles with high overall reporting scores.(7) Two trained investigators (R.”
MethodDevereaux, P. J., Choi, P. T.-L., El-Dika, S., Bhandari, M., Montori, V. M., Schünemann, H. J., Garg, A. X., Busse, J. W., Heels-Ansdell, D., Ghali, W. A., et al. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.03.017 · Cited by 209
Cited by
Industry sponsorship and research outcome
Lundh, A., Lexchin, J., Mintzes, B., Schroll, J. B., & Bero, L. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000033.pub3 · Cited by 1,697
Turner, L., Shamseer, L., Altman, D. G., Weeks, L., Peters, J., Kober, T., Dias, S., Schulz, K. F., Plint, A. C., & Moher, D. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000030.pub2 · Cited by 740
Industry sponsorship and research outcome
Lundh, A., Sismondo, S., Lexchin, J., Busuioc, O. A., & Bero, L. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.mr000033.pub2 · Cited by 605
Bouça-Machado, R., Rosário, M., Alarcão, J., Correia-Guedes, L., Abreu, D., & Ferreira, J. J. (2017) · BMC Palliative Care · doi:10.1186/s12904-016-0181-9 · Cited by 95
“Lai [47], in a systematic review of primary treatment in brain tumours, suggested that allocation concealment, blinding, type of analyses and details of randomisation were the poorly reported aspects because of the researcher difficulty in reporting this type data and due to the lack of awareness of the importance of…”
BackgroundGhimire, S., Kyung, E., Lee, H., & Kim, E. (2014) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2013.10.012 · Cited by 76
Metadata
- Authors
- Lai, R., Chu, R., Fraumeni, M., & Thabane, L.
- Venue
- Journal of Clinical Oncology
- Published
- 2006-03-01
- Volume
- 24
- Issue
- 7
- Pages
- 1136-1144
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2164796487
- Cited by
- 95
- References
- 5
- FWCI
- 5.27
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.